Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Finja Schweitzer

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Journal of the International AIDS Society|November 15, 2014
Longitudinal comparison of HIV-1 plasma viral load and cellular proviral loadFinja Schweitzer, Visa Mikkola, Monika Timmen-Wego, et al.
Current Opinion in Neurology|March 12, 2021
Neuro-COVID-19 is more than anosmia: clinical presentation, neurodiagnostics, therapies, and prognosisFinja Schweitzer, Nina N Kleineberg, Yasemin Göreci, et al.
Frontiers in Immunology|December 23, 2022
A therapeutic vaccine strategy to prevent <i>Pneumocystis</i> pneumonia in an immunocompromised host in a non-human primate model of HIV and <i>Pneumocystis</i> co-infectionWhitney Rabacal, Finja Schweitzer, Heather M Kling, et al.
AIDS Research and Human Retroviruses|September 20, 2018
Monocyte and Alveolar Macrophage Skewing Is Associated with the Development of Pulmonary Arterial Hypertension in a Primate Model of HIV InfectionFinja Schweitzer, Rebecca Tarantelli, Emily Rayens, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 22, 2026
HPV125-induced generalized verrucosisSven Niklas Burmann, Ulrike Wieland, Finja Schweitzer, et al.
Journal of Neurology|July 22, 2020
A systematic review of neurological symptoms and complications of COVID-19Xiangliang Chen, Sarah Laurent, Oezguer A Onur, et al.
Current Opinion in Neurology|April 16, 2019
Age and the risks of high-efficacy disease modifying drugs in multiple sclerosisFinja Schweitzer, Sarah Laurent, Gereon R Fink, et al.
Journal of Neurology|December 19, 2025
Serum neurofilament light chain as a biomarker of disease control in multiple sclerosis: a real-world cross-sectional analysis of therapeutic regimensAgni M Konitsioti, Finja Schweitzer, Wibke Johannis, et al.
Scientific Reports|December 29, 2019
Statin treatment prevents the development of pulmonary arterial hypertension in a nonhuman primate model of HIV-associated PAHWhitney Rabacal, Finja Schweitzer, Emily Rayens, et al.
Neurology|July 24, 2023
Progressive Multifocal Leukoencephalopathy: Pathogenesis, Diagnostic Tools, and Potential Biomarkers of Response to TherapyFinja Schweitzer, Sarah Laurent, Irene Cortese, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Journal of the International AIDS Society|November 15, 2014
Longitudinal comparison of HIV-1 plasma viral load and cellular proviral loadFinja Schweitzer, Visa Mikkola, Monika Timmen-Wego, et al.
Current Opinion in Neurology|March 12, 2021
Neuro-COVID-19 is more than anosmia: clinical presentation, neurodiagnostics, therapies, and prognosisFinja Schweitzer, Nina N Kleineberg, Yasemin Göreci, et al.
Frontiers in Immunology|December 23, 2022
A therapeutic vaccine strategy to prevent <i>Pneumocystis</i> pneumonia in an immunocompromised host in a non-human primate model of HIV and <i>Pneumocystis</i> co-infectionWhitney Rabacal, Finja Schweitzer, Heather M Kling, et al.
AIDS Research and Human Retroviruses|September 20, 2018
Monocyte and Alveolar Macrophage Skewing Is Associated with the Development of Pulmonary Arterial Hypertension in a Primate Model of HIV InfectionFinja Schweitzer, Rebecca Tarantelli, Emily Rayens, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 22, 2026
HPV125-induced generalized verrucosisSven Niklas Burmann, Ulrike Wieland, Finja Schweitzer, et al.
Journal of Neurology|July 22, 2020
A systematic review of neurological symptoms and complications of COVID-19Xiangliang Chen, Sarah Laurent, Oezguer A Onur, et al.
Current Opinion in Neurology|April 16, 2019
Age and the risks of high-efficacy disease modifying drugs in multiple sclerosisFinja Schweitzer, Sarah Laurent, Gereon R Fink, et al.
Journal of Neurology|December 19, 2025
Serum neurofilament light chain as a biomarker of disease control in multiple sclerosis: a real-world cross-sectional analysis of therapeutic regimensAgni M Konitsioti, Finja Schweitzer, Wibke Johannis, et al.
Scientific Reports|December 29, 2019
Statin treatment prevents the development of pulmonary arterial hypertension in a nonhuman primate model of HIV-associated PAHWhitney Rabacal, Finja Schweitzer, Emily Rayens, et al.
Neurology|July 24, 2023
Progressive Multifocal Leukoencephalopathy: Pathogenesis, Diagnostic Tools, and Potential Biomarkers of Response to TherapyFinja Schweitzer, Sarah Laurent, Irene Cortese, et al.
Pageof 3